E-ISSN:2456-3110

Research Article

Swetapradara

Journal of Ayurveda and Integrated Medical Sciences

2022 Volume 7 Number 10 November
Publisherwww.maharshicharaka.in

Comparative Study between Yoni Dhavan, Oral Medicine and both therapy in the treatment of Swetapradara

Maiti A.1*
DOI: http://dx.doi.org/10.21760/jaims.7.10.2

1* Animesh Maiti, H.O.D & Professor, Department of Prasuti Tantra & Stri Roga, Belley Sankarpur Rajib Gandhi Memorial Ayurvedic College and Hospital, Belley Sankarpur, Kushdanga, West Bengal, India.

Swetapradara is a common and major problem in our country of female especially reproductive age. Total patients (60) were divided into three group i.e. Gr-A, Gr- B and Gr- C with clinical features of white vaginal discharge, itching of vulva, burning pain in vagina, low back pain, general weakness.Gr-A was treated with Yoni Dhavan (Vaginal irrigation) by a compound decoction. Gr- B was treated with oral medicine by Pusyanuga Churan.Gr- C was treated with both therapies i.e., Yoni Dhavan & Oral medicine. This comparative clinical trial was conducted to evaluate the efficacy of Gr-C which were confirmed that the effectiveness was better than other groups in the management of Swetapradara. This study observe a highly significant reduction in mean scores of clinical feature and overall compliance to the treatment was excellent in the Gr-C and p value of < 0.001 was considered highly significant.

Keywords: Swetapradara, Yoni Dhavan, Pusyanuga Churna

Corresponding Author How to Cite this Article To Browse
Animesh Maiti, H.O.D & Professor, Department of Prasuti Tantra & Stri Roga, Belley Sankarpur Rajib Gandhi Memorial Ayurvedic College and Hospital, Belley Sankarpur, Kushdanga, West Bengal, India.
Email: 		Animesh Maiti, Comparative Study between Yoni Dhavan, Oral Medicine and both therapy in the treatment of Swetapradara. J Ayu Int Med Sci. 2022;7(10):9-12.
Available From
https://www.jaims.in/jaims/article/view/2116

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2022-09-26 2022-10-03 2022-10-10 2022-10-17 2022-10-23
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
Nil Nil Yes 17%

© 2022by Animesh Maitiand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Journal of Ayurveda and Integrated Medical Sciences 2022;7(10)9
Maiti A: Yoni Dhavan, Oral Medicine and both therapy in treatment of Swetapradara

Introduction

Swetapradara is a common problem in women specially during reproductive age. It is two combination word that is Sweta and Pradara. Sweta means white and Pradara means discharge. So, Swetapradara means white vaginal discharge. The word Swetapradara has not mentioned in Brihatroyi i.e., Caraka, Susruta and Vagbhata Samhitas. Swetasrava and Yonisrava words have been used in case of white vaginal discharge in Brihatroyi. But later commentator Cakrapani, Sarangadhar, Bhavaprakas and Yogaratnakara have used the word Swetapradara for white vaginal discharge. In this study Yoni Dhavan in Gr-A, Oral medicine in Gr-B and both therapy in Gr-C were selected for the treatment of Swetapradara.

Aims and Objectives

1. To evaluate the role of Yoni Dhavan (vaginal irrigation) by a compound decoction.

2. To evaluate the role of oral medicine.

3. To evaluate the efficacy of both therapy in the treatment of Swetapradara.

Study design: Prospective and comparative.

Materials and Methods

The study was conducted in the department of Prasuti Tantra and Stri Roga, B.S.R.G.M.A.C & Hospital, West Bengal, in which 60 patients were selected and were divided in three equal group i.e., Gr-A (20 Patients), Gr-B (20 Patients) and Gr-C (20 Patients).

Selection criteria: Patients were white vaginal discharge, itching of vulva, burning pain in vagina, low back pain and general weakness of women specially during reproductive age.

Exclusion criteria: Patients who were suffering from positive VDRL, carcinoma, positive pap smear, presence of other infective organism, were excluded from the study.

Selection and preparation of the drug: A compound decoction mentioned in Astanga Samgraha (Utt.39/97)[1] was selected for the study in Gr-A. The ingredients of the compound decoction are - stembark of Lodhra (Symplocos racemosa) and Vata (Ficus benghalensis).

Above two drugs were taken in equal parts and were made into a decoction. Another drug was Pusyanuga Churna mentioned in Bhaisajya Ratnavali (Stri Rogadhikar 66/25-31)[2] was selected for the study in Gr-B. The ingredients of the Pusyanuga Churan [3] are

1. Patha (Rt) - 1 Part

2. Jambu (Bija Majja) (Enm) - 1 Part

3. Amra (Bija Majja)(Enm) - 1 Part

4. Pasanbhed (Rz) - 1 Part

5. Rasanjana - 1 Part

6. Ambasthaki (Rt) - 1 Part

7. Mocarasa (Exd) - 1 Part

8. Manjistha (St) - 1 Part

9. Padma Kesara (Adr) - 1 Part

10. Kumkum (Stg) - 1 Part

11. Ativisa (Rt) - 1 Part

12. Musta (Rz) - 1 Part

13. Bilva (St.Bk) - 1 Part

14. Lodhra (St.Bk) -1 Part

15. Gairika - 1 Part

16. Katphala (Fr) - 1 Part

17. Maricha (Fr) - 1 Part

18. Sunthi (Rz) - 1 Part

19. Mrdvika (Dr.Fr) - 1 Part

20. Raktachandan(Ht.Wd)-1Part

21. Katvanga (St.Bk) - 1 Part

22. Kutaja (St.Bk) - 1 Part

23. Ananta (Rt) - 1 Part

24. Dhataki(Fl) - 1 Part

25. Yasti Madhu (Rt) - 1 Part

26. Arjun (St.Bk) - 1 Part

All the above drugs were taken in equal parts and made into a fine powder form.

Study procedure: The patients were equally divided into three groups. Each group was 20 patients.


Journal of Ayurveda and Integrated Medical Sciences 2022;7(10)10
Maiti A: Yoni Dhavan, Oral Medicine and both therapy in treatment of Swetapradara

Group A: This group was treated with Yoni Dhavan (vaginal irrigation) by decoction of Lodhra and Vata, morning and evening for 15 days.

Group B: This group was treated with Pusyanuga Churna - 3 gm orally twice daily with honey for 15 days.

Group C: This group was treated with both therapy i.e., Yoni Dhavan (vaginal irrigation) by decoction of Lodhra & Vata and Oral medicine by Pusyanuga Churan in the same dose for 15 days.

All groups were similar with regard to the demographic data and baseline parameters. Total score was based on white vaginal discharge, itching of vulva, burning pain in vagina, low back pain, general weakness, in the same parameters.

Discussion

Statistical analysis - Comparative study of the effectiveness between the Gr-A, Gr-B and Gr-C in different signs and symptoms before and after treatment (Table no. 1, 2 and 3).

Table 1: Result of the treatment in Group - A

Sign & Symptoms Mean ± S.D df ‘t’ value p value Effectiveness
BT AT
White vaginal discharge 2.5 3 ± 0.6 0.90 ± 0.7 24 9.25 <0.001  75.56
Itching of vulva 2.2 ± 0.6 0.66 ± 0.5 24 11.95 <0.001 80.00
Burning pain in vagina 1.11 ± 0.2 0.6 ± 0.13 14 3.30 <0.05 47.06
Low back pain 1.43 ± 0.5 0.44 ± 0.1 15 10.06 <0.001 72.62
General weakness 2.55 ± 0.4 1.2 ± 0.4 14 6.86 <0.001 65.00

Table 2: Result of the treatment in Group - B

Sign & Symptoms Mean ± S.D df ‘t’ value P value Effectiveness
BT AT
White vaginal discharge 2.13 ± 0.5 0.80 ± 0.5 24 9.12 <0.001  86.51
Itching of vulva 2.1 ± 0.5 0.40 ± 0.6 24 11.80 <0.001 90.15
Burning pain in vagina 1.09 ± 0.1 0.33 ± 0.11 14 5.89 <0.001 70.59
Low back pain 1.23 ± 0.4 0.42 ± 0.12 15 10.01 <0.001 73.15
General weakness 2.50 ± 0.35 0.46 ± 0.42 14 10.60 <0.001 78.00

Table 3: Result of the treatment in Group - C

Sign & Symptoms Mean ± S.D df ‘t’ value P value Effectiveness
BT AT
White vaginal discharge 2.01 ± 0.4 0.30 ± 0.4 24  9.15  <0.001  96.5
Itching of vulva 2.1 ± 0.3 0.31 ± 0.5 24  9.00 <0.001  95.50
Burning pain in vagina 1.10 ± 0.3 0.13 ± 0.90 14  709 <0.001  86.00
Low back pain 1.11 ± 0.3 0.30 ± 0.1 15  10.11 <0.001  80.50
General weakness 2.61 ± 0.12 0.2 5± 0.2 14  10.2 <0.001  85.00


Result

From the statistical point of view it was observed that out of 20 patients in Gr- A, 10 (50%) patients were cured, 2 (10%) patients were maximum improved, 3 (15%) patients were moderately improved, 5 (25%) patients were mildly improved and out of 20 patients in Gr- B, 15 (75%) patients were cured, 2 (10%) patients were maximum improved, 2 (10%) patients were moderately improved, 1 (5%) patients were mildly improved, whereas in the Gr- C, out of 20 patients, 18 (90%) patients were cured, 2 (10%) patients were maximum improved (Table no. 4).

Table 4: Overall clinical assessment of the treatment.

Result Group - A Group - B Group - C
No. of pt % of pt No. of pt % of pt No. of pt % of pt
Cured 10 50 % 15 75 % 18 90 %
Maximum improved 2  10 % 2 10 % 2 10 %
Moderately improved 3 15 % 2 10 % 0 0
Mildly improved 5 25 % 1 5 % 0 0

Conclusion

The study observed a highly significant reduction in the mean of white vaginal discharge, itching of vulva, burning pain in vagina, low back pain and general weakness. The overall compliance to the treatment was excellent in Gr-C than others group and the p value of <0.001 was considered highly significant. Hence, it can be concluded that the both therapies i.e., Yoni Dhavan and Oral medicine in Gr-C can be recommended for satisfactory management of Swetapradara.

Reference

1. Prof.K.R.Srikanth Murthy, Astanga Samgraha of Vagbhata, Vol- iii, Uttarsthana, 4th edition, Chaukhambha Orientalia, Varanasi, 2005,pp- 347.

2. Shri Gobinda Dasji, Bhaisajya Ratnavali, Vol-iii, 1st edition, Chaukhambha Sanskrit Bhawan, Varanasi, 2006, pp-343.

3. Govt. of India, The Ayurvedic Formulary of India, (part-1), First edition, Government of India press, Faridabad, 1978, pp- 91-92.


Journal of Ayurveda and Integrated Medical Sciences 2022;7(10)11